Search Results 2691-2700 of 16395 for Chronic Lymphocytic Leukemia

1. Health Coaching Post COVID - Mayo Clinic

   Participation eligibility · Male or female, ≥ 18 years of age. · Prior positive SARS-CoV-2 testing. · Persistent symptoms meeting diagnosis of PoCoS. · Access to ...

2. James T C Li, M.D., Ph.D. - Mayo Clinic Faculty Profiles

   Mayo Clinic researcher James T C Li, M.D., Ph.D., studies the diagnosis and treatment of drug allergies and the treatment of asthma.

3. Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil - Mayo Clinic

   About this study. The primary objective of this study is to evaluate the long-term safety and tolerability of LIQ861, a dry powder formulation of ...

4. A Study to Evaluate Smartphone-based Digital Phenotyping for Relapse Prediction in Alcohol-associated Liver Disease - Mayo Clinic

   Diagnosis of alcohol-associated liver disease and alcohol use disorder: The diagnosis of ALD will be determined by a hepatologist based on history of ...

5. A Study of Donor-Alloantigen-Reactive Regulatory T Cell Therapy with an Immunosuppression Regimen in Adult Liver Transplantation - Mayo Clinic

   Chronic condition requiring anti-coagulation after liver transplantation. Any chronic illness or prior treatment which, in the opinion of the investigator ...

6. HPV Infection Clinical Trials

   A Study to Validate HPV DNA Genotyping and Prognostic Genomic Biomarkers for Diagnosis Rochester, MN. The primary purpose of this study is to assess novel ...

7. A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Patients - Mayo Clinic

   Participation eligibility · Age ≥ 18 years old. · Confirmed diagnosis of PMF in accordance with the World Health Organization (WHO) 2016 criteria, or Post-PV/ET ...

8. A Study to Evaluate APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS) - Mayo Clinic

   Documented diagnosis of MDS, according to World Health Organization (WHO) classification. Patient has adequate organ function as defined by the following ...

9. Pharmacogenomic Testing Clinical Trials - Mayo Clinic Research

   Pharmacogenomic testing. Displaying 21 studies. A Study of Pharmacogenomics Results and Clinical Data of Patients with Chronic Myeloid Leukemia and Lung Cancer ...

10. A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving ABBV-383 as an Intravenous (IV) Infusion - Mayo Clinic

    - Diagnosis of primary systemic immunoglobulin light chain (AL) amyloidosis. ... - Previous or current diagnosis ... - Active plasma cell leukemia (i.e., either 20% ...